PCDHGA12 is a calcium-dependent cell-adhesion molecule belonging to the protocadherin gamma subfamily, predicted to function in establishing and maintaining neuronal connections [UniProt annotation]. The protein localizes to the plasma membrane and mediates cell-cell adhesion through calcium-dependent interactions [GO annotations]. Beyond its neurobiological role, PCDHGA12 has emerged as a significant biomarker in cancer biology. In lung cancer, PCDHGA12 expression is downregulated in both adenocarcinoma and squamous cell carcinoma tissues, with differential prognostic impact: high expression correlates with poor overall survival specifically in squamous cell carcinoma through altered DNA repair and immune infiltration pathways 1. PCDHGA12 was identified as one of 64 genes in a predictive signature for stage I NSCLC patient survival, associated with cancer metastasis processes 2. In breast cancer, PCDHGA12 represents one of ten genes in a cyclophosphamide-response prognostic signature 3. Epigenetically, PCDHGA12 promoter methylation serves as a diagnostic biomarker: methylation is associated with acute lymphoblastic leukemia detection 45, bladder cancer 6, and lung cancer diagnosis via bronchial washings, achieving 74.4% sensitivity and 91.9% specificity when combined with CDO1 methylation 7. These findings suggest PCDHGA12 functions dually as a cell-adhesion regulator in neural development and as an epigenetic biomarker for cancer detection and prognosis.